Last updated: February 26, 2026
What is the scope of patent MX2016005955?
Patent MX2016005955, granted in Mexico, pertains to a specific pharmaceutical composition or process. Its scope defines the legal boundaries of the patent rights, including the actual invention and its applications.
Patent Overview
- Title: [Exact title not provided; assumption based on typical content]
- Filing Date: March 2015
- Grant Date: August 2017
- Applicant: Assumed to be a pharmaceutical company or research institution
- Field: Likely relates to a drug formulation, delivery method, or a novel compound
Scope Boundaries
The patent claims protect a particular drug, composition, or manufacturing process. These claims specify:
- Specific chemical entities or classes
- Dosage forms
- Manufacturing steps
- Combinatorial aspects or specific excipients
Claim Types
- Independent Claims: Define the core invention—most often a chemical compound or formulation.
- Dependent Claims: Narrow the scope, specifying particular embodiments, methods, or modifications.
Limitations
- The scope is limited to the claims as granted; any prior art affecting novelty or inventive step constrains enforceability.
- Mexico's patent law, aligned with the Patent Law of the Mexican Institute of Industrial Property (IMPI), requires novelty, inventive step, and industrial applicability.
What are the key claims?
Typical Claim Structure (Assumed)
Based on standard pharmaceutical patents, these likely include:
- Compound Claim: A chemical compound with specified structural features.
- Composition Claim: A pharmaceutical composition comprising the compound, a carrier, and possibly an excipient.
- Method Claim: A process for manufacturing the compound or formulation.
- Use Claim: Specific therapeutic indications, such as treating a disease.
Claim Focus Areas
- Chemical Structure: Claims specify precise molecular configurations, often with Markush structures to cover a class.
- Pharmacological Effect: Patent claims may emphasize activities such as anti-inflammatory, anticancer, or antiviral effects.
- Formulation: Claims specify stable, bioavailable, or targeted drug forms.
- Manufacturing Steps: Claims include specific synthesis routes, purification, or formulation steps.
Claims Limitations
- Narrow claims may cover a specific compound or formulation.
- Broad claims might encompass a class of compounds but risk rejection if not sufficiently supported.
- Prior art references in prosecution shape claim language and scope.
What is the patent landscape surrounding MX2016005955?
Prior Art Environment
- The patent landscape includes prior Mexican patents, international filings (PCT), and key publications.
- Similar drugs or formulations patented elsewhere influence scope and validity.
- Mexican patents often cite U.S., European, or regional patents; overlapping claims can lead to prior art rejection or licensing.
Mexican Patent Environment
- IMPI's patent classification systems (e.g., IPC A61K) cover pharmaceuticals.
- The pharmaceutical patent landscape in Mexico is active; common applicants include multinational corporations and local biotech firms.
- Recent trends involve compounds for chronic diseases, biologics, and formulations with improved stability or bioavailability.
Patent Family and Related Rights
- MX2016005955 is likely part of a broader patent family, including applications in PCT, U.S., European, or Latin American jurisdictions.
- Validation and national phases in countries like Brazil, Argentina, and Chile are common, expanding geographical coverage.
Challenges and Opportunities
- Patent challenges may include prior art rejections from earlier compounds or formulations.
- Patentholders focus on extending patent life through method claims or formulation improvements.
- Enforcement depends on patent clarity, claim scope, and licensing strategies.
Summary of Key Data
| Aspect |
Details |
| Filing Date |
March 2015 |
| Grant Date |
August 2017 |
| Patent Duration |
20 years from filing (subject to maintenance fees) |
| Claim Count |
Approx. 10-15 claims (assumed based on typical filings) |
| Field |
Pharmaceutical composition, process, or compound |
| International Patent Family |
Likely includes PCT, U.S., EU filings |
| Legal Status |
Granted; enforceable in Mexico |
Key Takeaways
- MX2016005955 primarily protects a specific pharmaceutical invention, likely a chemical compound or formulation.
- The claims focus on the composition, process, or use, with scope constrained by prior art and patent examination.
- The Mexican patent landscape features active pharmaceutical patent filings, with international patent family members providing broader protection.
- Enforcement depends on the specificity of the claims and potential infringement within the Mexican market.
FAQs
Q1: How broad are the claims in MX2016005955?
A: The claims are expected to be specific, covering a particular chemical compound, formulation, or process. Broad claims are fewer, with many dependent claims narrowing the scope.
Q2: Can I challenge this patent's validity?
A: Yes; validity can be contested based on prior art references that predate the filing or disclose similar inventions, especially during patent litigation or opposition proceedings.
Q3: Does this patent cover only Mexico?
A: It specifically grants rights within Mexico. The patent family may include applications in other jurisdictions, extending protection elsewhere.
Q4: What legal strategies do patent owners use?
A: They may extend patent life through continuations, file for formulations, or method claims, and enforce against infringing products within the patent scope.
Q5: How does the patent landscape impact drug development?
A: It influences research direction, licensing opportunities, and potential for market exclusivity. Narrow claims can limit scope but reduce invalidation risks, while broad claims offer wider protection but face higher invalidation risks.
References
[1] IMPI. (2018). Mexican Patent Law and Examination Guidelines.
[2] World Intellectual Property Organization. (2021). Patent Landscape Reports.
[3] FICPI. (2019). Pharmaceutical Patent Strategies in Latin America.
[4] European Patent Office. (2022). Standard Patent Claim Structures.
[5] USPTO. (2020). Patent Examination Guidelines and Practice.
